GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: BMS-188667 | CTLA4-IgG4m | Orencia® | RG-1046 | RG-2077
abatacept is an approved drug (FDA (2005), EMA (2005))
Compound class:
Peptide
Comment: Abatacept is a recombinant protein fusing the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) to the modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1) [3]. In essence, abatacept is a CTLA-4 mimetic, that enhances CTLA-4's inhibitory signal to T cells, thereby down-modulating T cell mediated inflammation.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖
View more information in the IUPHAR Pharmacology Education Project: abatacept |
Classification  |
|
| Compound class | Peptide |
| Ligand families/groups | Immune checkpoint modulators |
| Approved drug? | Yes. EU EMA (2005) | US FDA (2005) |
| International Nonproprietary Names |
|
| INN number | INN |
| 8495 | abatacept |
| Synonyms |
| BMS-188667 | CTLA4-IgG4m | Orencia® | RG-1046 | RG-2077 |
| Database Links |
|
| Specialist databases | |
| IMGT/mAb-DB | 212 |
| Other databases | |
| ChEMBL Ligand | CHEMBL1201823 (Hs) |
| DrugBank Ligand | DB01281 |
| GtoPdb PubChem SID | 178103473 |
| PubChem SID | 135355129 |
| Search PubMed clinical trials | abatacept |
| Search PubMed titles | abatacept |
| Search PubMed titles/abstracts | abatacept |
| Wikipedia | Abatacept |
